NB

Nathan Benaich

Founder of Spinout.fyi

London, England

Overview 

Nathan Benaich is a General Partner at Air Street Capital in London, with a background in entrepreneurship, research, and lifesciences. He co-authored the State of AI Report and has invested in companies like GOURMEY and Valence Discovery, focusing on sectors such as BioTech and AI. Benaich holds a PhD and MPhil from the University of Cambridge and has made significant investments in various stages and sectors, including Series A and Seed funding for companies like Profluent Bio and Contextual AI.

Work Experience 

  • Solo Member of Investment Staff

    2019 - Current

    Adept AI (acq. Amazon), Allcyte (acq. Exscientia), Anagenex, Athenian, CellVoyant, ClipDrop (acq. Stability.ai/Jasper), Enveda Biosciences, Exscientia (NASDAQ: EXAI, merged w/Recursion), Fern Labs, Gandeeva Therapeutics, Gourmey, Graphcore (acq. SoftBank), Hedera Dx, Intenseye, Interloom, LabGenius, Delian AI (fka. Lambda Automata), Mission Barns, Modern Intelligence, Odyssey, Patina Systems, Polar Mist, Poolside, Profluent, Recursion Pharmaceuticals (NASDAQ: RXRX), Samaya.ai, Sereact, Synthesia, V7, Valence Discovery (acq. Recursion), ZOE, and several unannounced.

  • Author

    2015

    Ideas worth propagating.

  • Author

    2018

    The definitive annual report on AI progress.

  • Founder

    2021

    Rewriting the university spinout playbook.

  • Scientist in Residence

    2017

  • Other things

    2013

    > Author: State of AI Report, Guide to AI newsletter. > Founded: RAAIS, RAAIS Foundation, London.AI > Angel: Tractable, Niantic, Wayve, Ndea, Lambda Labs, ElevenLabs, Recursion (NASDAQ: RXRX), Synthesia, Crusoe Energy, Optimal Labs, PolyAI, KyraTV, The Engineering Company, Secondmind, ONI.bio, Kepler Computing, 20bn (acq. Qualcomm), Motion, Muon Space, Detail, Incident.io, Quench, LabGenius, Synq, Kanna Health, Objective (acq. Upwork), Contextual.ai, Chroma, and All Hands AI. > Previously: Playfair Capital

Articles About Nathan

Relevant Websites